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In this work, innovatory production of three radioisotopes 117mSn, 186Re
and 188Re, which can be used in nuclear medicine, is described. The natu-
ral tin and rhenium targets were irradiated by a high-energy 20 MV X-ray
therapeutic beam from a medical linear accelerator. Additionally, the tar-
gets were in the photoneutron field. The radioisotopes were obtained in
photonuclear and neutron reactions. A special lead-PMMA system was
used to increase the slowed-down neutron flux in the target volume. The
specific activities of 117mSn, 186Re and 188Re are 11 kBq/g, 2.6 MBq/g and
0.26 MBq/g in the saturation state, respectively. The produced amounts
of the radioisotopes of tin and rhenium are sufficient for various laboratory
tests in nuclear medicine.
DOI:10.5506/APhysPolB.51.867
1. Introduction
In the last decade, several independent reactor shutdowns and outage ex-
tensions have significantly disrupted global radioisotope supplies [1]. There-
fore, new methods of production of radioisotopes for nuclear medicine ap-
plications are required. The goal of this work was to extend our previous
studies [2, 3] and to test a possibility of production of three prospective
medical radionuclides: 117mSn, 186Re and 188Re, using medical linacs.
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117mSn is a diagnostically promising radioisotope, because it emits γ rays
of 158.6 keV, which is close to the energy of 99mTc. The half-life (T1/2)
of 13.6 days and the γ decay to the stable state with a some amount of
conversion electrons make this tin isomer an ideal alternative to 99mTc,
especially considering the fact that the latter is contaminated with 99Mo
and when used in radio-pharmaceutical injections provides an unnecessary
radiation dose to the patients [4, 5]. Until now, 117mSn was only suggested
as an effective agent for the palliation of pain from bone metastases [6–8].
However, it is absent in the list of diagnostic radioisotopes because of its
inefficient production in nuclear reactors.
186Re (T1/2 = 90.64 h) disintegrates by electron capture (EC) and β+
(6.9%) and β− (93.1%) decays. It emits γ rays with energies of 122.58 keV
and 137.16 keV. Another rhenium radioisotope, 188Re, (T1/2 = 16.98 h)
disintegrates by β− decay and emits γ rays of 155.0 keV. The rhenium ra-
dioisotopes are used in the radiation therapy of elbow, hip and ankle joints
of the youth [9]. The possibility of their production in medical linear ac-
celerators installed almost in each oncology centre certainly contributes to
studies on new applications of these radioisotopes in nuclear medicine.
2. Materials and methods
2.1. Characteristics of targets and reactions
Targets of natural tin and rhenium were irradiated at the Oncology Cen-
tre in Gliwice (Poland) using high-energy 20 MV X-ray therapeutic beams
from two Varian medical linear accelerators: Clinac-2300 and TrueBeam.
These radiotherapy systems are often equipped with such high-energetic pho-
ton beams. The high-energy photons induce photonuclear reactions (γ, n) in
which radioisotopes as well as neutrons contaminating a therapeutic beam
are produced [10–16]. These neutrons may induce some secondary reac-
tions. The targets were mounted on the accelerator window in the thera-
peutic beam. Thus, they were activated both by high-energy photons and
by neutrons. For rhenium, the targets were in a film form (57–60 mg/cm2),
whereas in the case of tin, they were small plastic containers filled with a
tin powder (1.048–1.143 g/cm2).
Three of ten natural stable tin isotopes were used for production of
117mSn i.e. 116Sn (abundance of 14.54%), 117Sn (7.68%) and 118Sn (24.23%).
117mSn originated from the photonuclear reaction 118Sn(γ, n)117mSn and
from two reactions induced by neutrons: 116Sn(n, γ)117mSn and
117Sn(n, n′)117mSn. The maximum photonuclear cross section of 290 mb
corresponds to the photon energy of 15 MeV [17]. The neutron capture
cross section does not exceed 6 mb [18]. The cross section for production of
117mSn in the neutron inelastic scattering reaction does not exceed 0.1 b [18]
and a neutron energy over 317.2 keV is required.
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Two natural stable rhenium isotopes: 185Re (37.4%) and 187Re (62.6%),
were activated in the following reactions: 187Re(γ, n)186Re, 185Re(n, γ)186Re
and 187Re(n, γ)188Re. The maximum photonuclear cross section is about
420 mb at 13 MeV [17] for 187Re. The cross sections of the thermal neu-
tron capture reactions are 120 b and 80 b [18, 19] for 185Re and 187Re,
respectively. Moreover, these isotopes have many very large resonances for
neutron capture, reaching even several tens of thousands barns in the energy
range from 2 eV to about 1 keV [19]. Additionally, the fast neutron reaction
187Re(n, 2n)186Re occurs for energies higher than 7.75 MeV (the maximum
cross section of 2.24 b at 14.25 MeV) [20].
2.2. Experimental system and determination of the obtained activities
The location of a target during its irradiation is presented in Fig. 1. The
lead-PMMA system located on the beam path was applied to increase the
slowed-down neutron flux in the target. The 5 cm thick lead block was an
additional neutron source, whereas the 10 cm PMMA layer was a neutron
moderator and enhanced the neutron scattering.
Fig. 1. A target located on the accelerator window and the lead-PMMA system.
The activities of the produced radioisotopes were determined from the
measured γ-ray spectra of the radioactive decays. The spectra were acquired
by means of two similar HPGe semiconductor detectors. The detection
efficiency was ε = 0.5% at 1332 keV (60Co) for a source located in the centre
of the upper surface of the aluminum detector shield (ε = Nmeas/Nemit
in %, Nmeas — the number of counts (photons) observed by the detector,
Nemit — the number of photons emitted by the source). The resolution of
the detection setup was 1.2 keV at 1332 keV. The multiple samples were
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measured separately in singles mode in two HPGe detectors. The energy
and efficiency calibrations of the detectors were carried out with commercial
sources of 152Eu, 133Ba and 60Co. The summing effect was corrected by
means of Monte Carlo simulation (Geant4 [21]). Each detector was connected
to a multichannel analyser controlled by the Tukan8k software [22], also
applied to calculate the photopeaks’ net areas and, susequently, the activities
of the radiosotopes produced in the targets.
3. Results and discussion
The γ-ray spectra representing the produced radioisotopes of tin and
rhenium are presented in Fig. 2 (irradiation time: 15 minutes, beam rate:
600 monitor units per minute, which corresponds to 1012 photons per cm2
per second on the surface of the accelerator window). The slowed-down
neutron flux was 105 per cm2 per second in the target volume [15].
Fig. 2. The HPGe γ-ray spectra of the radioisotopes produced using targets of
natural tin (a) and rhenium (b). A contamination by the radioisotopes of 111In
(T1/2 = 2.81 d) and 184Re (139 h) is visible.
Employing the targets with a natural composition of tin and rhenium
leads to the appearance of contaminations with the radioisotopes such as of
111In and 184Re. 111In is a result of the radioactive decay of 111Sn originat-
ing from the photonuclear reaction 112Sn(γ, n) 111Sn. The maximum cross
section of this reaction is only 290 mb, the abundance of 112Sn is only 0.97%
and the half-life of 111Sn (35.3 minutes) is relatively short. In consequence of
the latter, it is easy to remove 111In from the target, because the half-life of
117mSn is almost five times longer than the half-life of the undesirable indium
radioisotope (T1/2 = 2.81 d). In the case of the Re target, such separation of
radioisotopes is impossible, because 184Re (resulting from 185Re(γ, n)184Re,
420 b at 15 MeV) has a half-life of 169 h, thus being longer than the half-lives
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of the radioisotopes of 186Re and 188Re. The specific activity increased by
using enriched tin with only the isotopes involved in the reactions of inter-
est ensure that no 111Sn is produced. The use of a target enriched in the
heaviest rhenium isotopes limits the production of 184Re.
The saturation curves for the produced radioisotopes are shown in Fig. 3.
The saturation of activity of 186Re is reached after about 400 hours of irra-
diation, whereas in the case of 188Re, it is observed after about 120 hours.
For 117mSn the longest irradiation time of about 2000 hours is needed to
reach the saturation state, because this isomer of tin has the half-life much
longer than the rhenium radioisotopes. The highest specific activity was
obtained for 186Re, being 2600 kBq/g in the saturation state, whereas the
lowest one of 11 kBq/g was measured for 117mSn, which is far less than for
the other rhenium isotope, 188Re (260 kBq/g). The specific activities differ,
because contrary to 117mSn, the produced rhenium radioisotopes have many
high resonances for the neutron-capture reaction. Moreover, 186Re can also
be produced in the (n, 2n) reaction induced by fast neutrons. The surfaces
of the beam windows (13.5 cm× 13.5 cm) in typical medical accelerators are
large enough to irradiate large targets and to get higher activities. The ac-
tivities of the considered radioisotopes obtained for the accelerator window
fully covered by the target and estimated for an irradiation time of 1 hour
are shown in Table I.
Fig. 3. The saturation curves for the activated targets located on the accelerator
window. Irradiation was performed with the use of the lead-PMMA system. The
curves were calculated on the base of a measurement lasting 15 minutes.
TABLE I
Estimated activity of produced radioisotopes for large 13.5 cm × 13.5 cm targets
activated in a 20 MV therapeutic beam for 1 h.
Target 117mSn 186Re 188Re
Activity 4.2 kBq 3.6 MBq 2.1 MBq
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4. Conclusions
The obtained specific activities, particularly those of 117mSn and 186Re,
are relatively low, which is mainly due to a relatively small neutron flux and
mismatching of the therapeutic photon spectrum and the photonuclear cross
sections. For the produced radioisotopes of tin and rhenium, the maximum
cross sections for photonuclear reactions fall within the energy range of 13–
15 MeV, while the photon energy spectrum of the 20 MV therapeutic beam
applied in this study has its maximum at about 4.5 MeV. This problem
was explained in details by Bzymek et al. [2]. When more massive targets
are used (e.g. the irradiated mother isotope covers the whole surface of
an accelerator window), the radioisotope yield can be increased. Such an
approach is effective because the photon and neutron fluences are almost
constant on the whole surface of the accelerator window. The radioisotopes
of tin and rhenium of increased activity can be applied in various laboratory
tests in nuclear medicine.
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